real-time news and commentary for investors
Wednesday, Jan 30
An orthopedic surgeon who helped design the all-metal hip implant that Johnson & Johnson...
An orthopedic surgeon who helped design the all-metal hip implant that Johnson & Johnson (JNJ -0.4%) recalled in 2010 says the device wasn’t defective as he testified in the first of thousands of cases set to go to trial. “I have not used the term ‘defective’” the surgeon testified in a videotaped deposition. JNJ claims the implant was properly designed and the plaintiff's claim of elevated metal levels in his body can be traced to conditions including diabetes, high blood pressure and cholesterol, strokes and kidney cancer.